You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

I am a:
${ profile.name.substring(0, profile.name.length - 1) }
Request Info

Xpert® Norovirus

Accurate and Easy to Use with Fast Results When Time Matters

Product Resources MyCepheid Store
Xpert<sup>®</sup> Norovirus

The Need

Norovirus is a highly contagious virus and is the most common cause of viral gastroenteritis worldwide. Globally, the virus affects approximately 267 million people and causes over 200,000 deaths each year.1

  • Norovirus outbreaks in healthcare institutions require immediate implementation of infection control measures to avoid ward closures
  • Patients with acute diarrhea should be placed into isolation until proven non-infectious2
  • The majority of Norovirus infections are caused by genotype I & genotype II (GI & GII) — both of which must be tested for to ensure proper outbreak prevention and management

(1) Debbink K, et al. Norovirus Immunity and the Great Escape. PLoS Pathog. 2012 Oct; 8(10): e1002921.
(2) MacCannell T, et al. Guideline For The Prevention and Control of Norovirus Gastroenteritis Outbreaks in Healthcare Settings. CDC. 2017. Accessed May 2020. https://www.cdc.gov/infectioncontrol/pdf/guidelines/norovirus-guidelines.pdf

The Solution

Controlling a Norovirus outbreak requires an accurate, easy-to-use test that detects Noroviruses of genogroup I (GI) and genogroup II (GII), which are responsible for the majority of infections.

Xpert Norovirus delivers:

  • High sensitivity and specificity with results in as little as one hour*, delivering accurate and actionable results for immediate decisions
  • Accurate identification of norovirus infections can help ensure adequate isolation management
  • Laboratory efficiencies with on-demand workflows requiring less than one minute of hands-on time
  • Optimized management of isolation beds for improved patient management and reduced costs

* with EAT (Early Assay Termination), for positive results

The Impact

Having an accurate and fast Norovirus test provides actionable information for clinicians to improve patient management and outcomes. Xpert Norovirus provides efficient use of your valuable resources in identifying, preventing and managing outbreaks.

Accelerate your laboratory’s workflow

  • Deliver same day results to clinicians in as little as one hour*
  • Instrument consolidation lowers operating costs while increasing laboratory service
  • Implement immediate infection control policies to reduce transmission, improve patient management and health outcomes

* with EAT (Early Assay Termination), for positive results

Ordering Info

Xpert® Norovirus

Number of Tests: 10

Catalog #: GXNOV-10

Educational Materials

#carousel-educational-materials-0 .carousel-layout > .row > div[class*="col"]:nth-child(n + ${ activeRow * colCount + 1 }$), #carousel-educational-materials-0 .carousel-layout > .row > div[class*="col"]:nth-last-child(n + ${ storyCount - (activeRow - 1) * colCount + 1}$) { visibility: hidden; max-height: 0px; overflow: hidden; margin-bottom: 0; opacity: 0; left: 30px; }
VAMC Houston
DOCUMENT

VAMC Houston

By providing actionable results to clinicians when needed most, VAMC Houston has improved their efficiency and effectiveness of care by implementing Cepheid’s GeneXpert® Infinity System. Infectious disease tests that typically take days to result can lead to high rates of transmission and subsequent healthcare-associated infections (HAI). Incorporating Cepheid’s one hour PCR technology, MRSA colonized and C. difficile positive patients are quickly identified and isolated, resulting in lower healthcare-associated infection rates.

White Paper: Supporting CDC’s Four Core Actions to Fight Antimicrobial Resistance
DOCUMENT

White Paper: Supporting CDC’s Four Core Actions to Fight Antimicrobial Resistance

CDC has declared the complex problem of AMR a serious threat today, which will result in potential catastrophic consequences with continued inaction. To combat AMR, the CDC has identified 4 core actions, all of which can be addressed through rapid molecular diagnostics:

Webinar: RDT+ASP: How New Rapid Diagnostics are Supercharging Antimicrobial Stewardship Programs
WEBINAR

Webinar: RDT+ASP: How New Rapid Diagnostics are Supercharging Antimicrobial Stewardship Programs

This webinar discusses data supporting the combination of rapid diagnostic tests (RDT) and antimicrobial stewardship programs (ASPs), reviews RDT systems, and provides guidance on how ASPs can implement and optimize the use of RDTs in virtually any healthcare setting.

Back to Top